Post Inflammatory Hyperpigmentation Recruiting Phase 2 / 3 Trials for Tranexamic acid (DB00302)

Also known as: Postinflammatory Hyperpigmentation / Post-inflammatory Hyperpigmentation / Postinflammatory hyperpigmentation (morphologic abnormality) / Post-inflammatory hyperpigmentation (disorder) / Post inflammatory pigmentation change

IndicationStatusPhase
DBCOND0045798 (Post Inflammatory Hyperpigmentation)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03361345Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne VulgarisTreatment